These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 29029193)
21. Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial. Braithwaite VS; Mwangi MN; Jones KS; Demir AY; Prentice A; Prentice AM; Andang'o PEA; Verhoef H Am J Clin Nutr; 2021 May; 113(5):1104-1114. PubMed ID: 33675347 [TBL] [Abstract][Full Text] [Related]
22. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. Imel EA; Hui SL; Econs MJ J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222 [TBL] [Abstract][Full Text] [Related]
23. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Taylor EN; Hoofnagle AN; Curhan GC Clin J Am Soc Nephrol; 2015 Apr; 10(4):667-75. PubMed ID: 25623233 [TBL] [Abstract][Full Text] [Related]
29. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease. Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404 [TBL] [Abstract][Full Text] [Related]
30. High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4. Tsai MH; Leu JG; Fang YW; Liou HH Medicine (Baltimore); 2016 Mar; 95(11):e3049. PubMed ID: 26986127 [TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay. Rousseau AF; Souberbielle JC; Delanaye P; Damas P; Cavalier E Burns; 2016 Aug; 42(5):1082-1087. PubMed ID: 27215149 [TBL] [Abstract][Full Text] [Related]
32. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure. van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688 [TBL] [Abstract][Full Text] [Related]
33. Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children. Braithwaite V; Jones KS; Assar S; Schoenmakers I; Prentice A Endocr Connect; 2014; 3(1):1-10. PubMed ID: 24258305 [TBL] [Abstract][Full Text] [Related]
34. FGF23 is elevated in Gambian children with rickets. Prentice A; Ceesay M; Nigdikar S; Allen SJ; Pettifor JM Bone; 2008 Apr; 42(4):788-97. PubMed ID: 18234575 [TBL] [Abstract][Full Text] [Related]
35. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M; Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495 [TBL] [Abstract][Full Text] [Related]
36. Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults. Nowak KL; Bartz TM; Dalrymple L; de Boer IH; Kestenbaum B; Shlipak MG; Garimella PS; Ix JH; Chonchol M J Am Soc Nephrol; 2017 Apr; 28(4):1239-1246. PubMed ID: 28122946 [TBL] [Abstract][Full Text] [Related]
37. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population? Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093 [TBL] [Abstract][Full Text] [Related]
38. Abnormalities in renal tubular phosphate handling in children with sickle cell disease. Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581 [TBL] [Abstract][Full Text] [Related]